$SOTK

Sono-Tek stock falls 14% on second quarter earnings, revenue miss

Sono-Tek (SOTK) reported Q2 fiscal 2027 earnings and revenue below estimates, with shares down 14.47% premarket. Revenue was $5.23M, up 1% YoY, while EPS was $0.02, missing estimates by $0.02. Medical sector sales surged 209% to $3.11M. The company maintained full-year guidance for flat to modest growth, citing order timing. Backlog increased 23% to $9.51M.

Original reporting
Published Oct 14, 2026, 11:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 11:21 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SOTK
Bearish
high confidence
Mentioned
$SOTK
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SOTKBearishHigh
01

Why it matters

The earnings miss triggered a sharp pre‑market decline, highlighting execution risk in large‑order timing.

02

Market read

Micro‑cap earnings miss with immediate price reaction; relevant for short‑term traders.

03

What to watch

Backlog increase and post‑quarter orders suggest near‑term revenue upside.

Relevance 6/10Novelty 7/10Timing: pre‑market today

Background

Sono‑Tek provides precision ultrasonic coating systems for medical and industrial markets.

Company-level read

Ticker impact

$SOTKBearishHigh confidence
Context

Sono‑Tek reported Q2 FY2027 earnings and revenue miss, causing a 14.5% pre‑market drop.

Expected impact

downward pressure as the market prices in the earnings shortfall

Evidence & confidence

Adjusted EPS of $0.02 missed consensus $0.04 and revenue fell short, prompting immediate sell‑off.

Market effects

Ultrasonic coating equipment sector may see short‑term weakness as a peer misses estimates.

US micro‑cap market may experience modest sell pressure.

Limited; impact confined to niche manufacturing segment.

Counterpoint

If the medical‑segment growth sustains, the stock could rebound despite the miss.

Key entities

  • Steve Harshbarger

    President and CEO of Sono‑Tek, quoted on fiscal outlook.

Related articles

$SOTKMed

Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems First Half Revenue Increased 6% to $10.9 Million; Gross Margin Expanded to 55%; Operating Income Increased 41%; Medical Market Sales

$SOTKMed

Sono-Tek stock rises on record $3.6M production line order

Sono-Tek Corp (NASDAQ:SOTK) shares rose 3.9% premarket after the company said it received a $3.6 million order for an integrated advanced manufacturing production line for medical diagnostic device coating. Sono-Tek said it is its largest single-line order, placed by an existing customer moving to high-volume manufacturing, with shipment expected in fiscal 2028.

$SOTKMedAI 8/10

Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results

Sono-Tek (Nasdaq: SOTK) reported first-quarter fiscal 2027 results for the quarter ended May 31, 2026. Net sales rose 10% to $5.66 million, gross margin expanded to 57% from 52%, operating income increased 86% to $897,000, and net income rose to $741,000 ($0.05 diluted). Cash was $16.65 million with no debt, and backlog was $7.73 million. The company expects continued 1H growth driven by medical demand and higher-value production systems.

$SOTKMed

Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm SONO-TEK CORPORATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS Exhibit 99.1 Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results Revenue Increased 10%; Gross Margin Expanded to 57%; Operating Income Increased 86%; Net Income Increased 67% Anticipati

$SOTKMedAI 9/10

Sono-Tek Corporation Q4 2026 Earnings Call Summary

Sono-Tek Corporation reported Q4 2026 results driven by a shift to higher-ASP, turnkey production systems. The company said medical demand rose 54% year over year, while clean energy orders fell 19% amid government policy changes. Gross margin increased to 51% and operating income rose 81%. Management projected growth and profitability in fiscal 2027 H1, with flat-to-modestly higher full-year revenue amid clean-energy uncertainty. Cash was $14.8 million with no debt.